You have good embryos. Your uterine lining looks perfect on scan — thick, trilaminar, exactly as it should be. And yet the frozen embryo transfer (FET) failed. Again. If this sounds familiar, you are among the many IVF patients for whom the question "why doesn't it work?" has no obvious answer on standard investigations.
One possible answer is timing. Specifically, the possibility that your embryo was transferred at the wrong moment — not by much, perhaps just hours — but enough to miss the narrow window when your endometrium was truly ready to receive it. The ERA (Endometrial Receptivity Analysis) test was developed to identify exactly this: your personal window of implantation.
At Mother Hospitals & IVF Center, Boduppal, Hyderabad, Dr. E. Prashanthi Reddy uses ERA testing selectively — in the right patients, it is a genuinely useful investigation that can change the outcome of an FET cycle. This guide explains what ERA measures, who is most likely to benefit, what a displaced WOI means for your protocol, and whether the cost is justified.
What Is the Window of Implantation (WOI)?
The window of implantation is the brief period during each menstrual cycle — or during a medicated FET cycle — when the endometrium (uterine lining) is in a state that allows an embryo to attach, invade, and begin implanting. Outside this window, the endometrium is either not yet ready (pre-receptive) or has passed the receptive phase (post-receptive).
In a standard medicated FET cycle, oestrogen is given to grow the endometrial lining to the desired thickness. Then progesterone is added. The convention is that after 5 full days of progesterone (for a blastocyst-stage embryo), the endometrium should be in its receptive phase — and this is when the embryo transfer is performed. This works well for most women. But not for all.
Research has shown that approximately 25–30% of women have a WOI that is displaced — shifted slightly earlier or later than the standard 5-day progesterone point. In these women, transferring at the standard time consistently misses the receptive window, no matter how good the embryo quality or how perfect the lining looks on ultrasound. The ERA test identifies these women and determines their personal optimal transfer timing.
What Is the ERA Test and How Does It Work?
The ERA test is a molecular diagnostic test developed by IGENOMIX (Spain) and is now available at centres worldwide including India. It analyses the gene expression profile of a small endometrial biopsy to determine whether the endometrium is in a pre-receptive, receptive, or post-receptive state at the time of sampling.
The ERA Process
- Mock cycle: You undergo a medicated endometrial preparation cycle identical to your actual FET cycle — same oestrogen dose, same progesterone dose, same duration.
- Endometrial biopsy: On the day you would normally have your embryo transfer (after the standard 5 days of progesterone), a small biopsy of the endometrial lining is taken in the clinic. This is a brief, mildly uncomfortable procedure similar to an endometrial scratch — no anaesthesia required.
- Laboratory analysis: The biopsy is sent to the ERA laboratory. RNA is extracted from the endometrial cells and the expression of 248 genes known to be involved in endometrial receptivity is analysed.
- Result — personalised transfer time (pET): The report classifies your endometrium as pre-receptive, receptive, or post-receptive at the sampled time, and gives a personalised embryo transfer (pET) recommendation — for example, "transfer at 5.5 days of progesterone" or "transfer at 4.5 days of progesterone" instead of the standard 5 days.
- Your next FET: The actual embryo transfer is performed at your personalised pET timing. Most studies show significantly improved implantation rates when ERA-guided transfers are used in women with a displaced WOI.
Who Benefits Most From ERA? — The Right Patients
ERA is a targeted test, not a routine investigation for every IVF patient. The evidence supports its use most strongly in the following situations:
- Two or more failed FET cycles with good-quality euploid (PGT-A tested) embryos: When chromosomally normal embryos fail to implant repeatedly, a displaced WOI becomes a serious consideration. ERA is most clinically useful and cost-effective in this group.
- Recurrent implantation failure (RIF): Women who have had repeated IVF/FET failures with apparently good embryos and no other identified cause. ERA may reveal a displaced WOI as the missing piece of the puzzle.
- Women with endometriosis: Endometriosis is associated with altered gene expression in the endometrium, and displaced WOI appears more common in women with endometriosis. ERA may be particularly valuable before FET in this group.
- Women with PCOS or hormonal irregularities: The endometrial response to progesterone may vary, making standard timing less reliable.
ERA is less likely to be useful as a first-line investigation in women who have not yet had a failed FET, or in cases where a clearly identifiable cause of implantation failure (such as a uterine polyp, hydrosalpinx, or thin endometrium) has not yet been addressed.
What Does a Displaced WOI Mean for Your Protocol?
If ERA results show your WOI is displaced, the report will provide a specific pET (personalised embryo transfer) recommendation:
- Pre-receptive result: Your endometrium needs more time with progesterone. The recommendation might be to transfer at 5.5 or 6 days of progesterone instead of the standard 5 days.
- Post-receptive result: Your endometrium peaks earlier than standard. The recommendation might be to transfer at 4 or 4.5 days of progesterone.
- Receptive result: Your WOI is at the expected time — standard 5-day protocol is correct for you, and other causes of failure should be investigated.
In subsequent FET cycles, the progesterone supplementation timeline is adjusted to match your personalised window exactly, and the embryo transfer is performed at the pET time. The cycle preparation otherwise remains the same.
Is ERA Worth the Cost? — An Honest Assessment
The ERA test adds a significant cost to the IVF journey. Is it worth it? Here is an honest, evidence-based view:
- For women with 2+ failed FETs and good embryos: The evidence is reasonably supportive. Studies (including the MOSAICS trial and ERA validation studies) show improved implantation and live birth rates when ERA-guided pET is used in women with a displaced WOI. For this group, ERA can represent a cost-effective investment — preventing one or more additional failed FET cycles is emotionally and financially significant.
- For women having their first FET: Routine ERA is not recommended by most guidelines for first-time transfers. The majority of women have a standard WOI, and the test adds cost without clear benefit in unselected patients.
- For older women with limited embryos: If you have only 1–2 frozen embryos remaining and cannot afford another failed transfer, ERA may be worth doing before your next cycle even without a history of multiple failures — to maximise the chance of success with precious remaining embryos.
Dr. Prashanthi's View on ERA
"I recommend ERA selectively — to women who have had good embryos fail more than once, and where we have already excluded other causes of implantation failure such as uterine issues or thin lining. When ERA comes back with a displaced WOI and we adjust the timing for the next transfer, the results can be very gratifying. But it is not magic — it is one piece of a complex puzzle, and it needs to be put in context with everything else we know about the patient. I never recommend ERA to everyone — I recommend it to the patients most likely to benefit from it."
For more information on frozen embryo transfers at Mother Hospitals, visit our Frozen Embryo Transfer page in Hyderabad.